Susunod

Auto-play

Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms

2 Mga view • 07/29/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play